Join
Live feed
·
INSIDERFilingvia Quantisnow
Agile Therapeutics Inc. logo

SEC Form 4: Jason Butch bought $20,073 worth of Common Stock (10,000 units at $2.01), increasing direct ownership by 100% to 20,000 units

ByQuantisnow·Wall Street's wire, on your screen.
AGRX· Agile Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGRX (Agile Therapeutics Inc.) and more on Quantisnow.